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Abstract 
The effects of an acute systemic injection of methamphetamine (mAMP) or cocaine (COC) on motor behavior (stereotypy, 
locomotor activity, and rearing) and extracellular dopamine (DA) in the ventral striatum were compared in Lewis (LEW) versus 
Fischer 344 (F344) rats, using in vivo microdialysis in awake freely moving animals. In addition, the behavioral response to 
repeated mAMP injections (i.e. sensitization) was characterized in LEW and F344 rats, as was the possibility of strain differences 
in drug pharmacokinetics. The major findings were: (i) LEW rats showed greater behavioral activation to an acute injection of 
both mAMP and COC, as indicated by a shift to the left in the dose-effect curves relative to F344 rats. (ii) LEW rats were more 
susceptible to mAMP sensitization. (iii) An acute injection of mAMP or COC enhanced the extracellular concentration of DA to 
a greater extent in LEW rats, as indicated by a significant shift to the left in the dose-effect curve relative to F344 rats. (iv) 
Strain differences in the behavioral and neurochemical effects of these drugs were characterized largely by differences in the 
duration of the drug response. (v) LEW rats had higher plasma and brain levels of mAMP and COC than F344 rats, suggesting 
that strain differences in pharmacokinetics may contribute to strain differences in the behavioral and neurochemical effects of 
these drugs. 
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1. Introduct ion 
Humans show considerable individual variation in 
their response to addictive drugs [42]. This is also true 
of nonhuman animals, as indicated, for example, by 
individual variation in the acquisition of drug self-ad- 
ministration behavior [9,20,40]. The factors responsible 
for this variability are no doubt complex, and involve 
genetic and environmental factors, and their interac- 
tions. One approach to investigating the role of genetic 
factors in drug addiction in animals is to study inbred 
strains of animals. Two inbred strains of rats that have 
received considerable attention recently, because they 
show marked differences in their behavioral response 
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to a variety of addictive drugs, are Lewis (LEW) and 
Fischer 344 (F344) rats. For example, LEW rats show a 
greater propensity to orally self-administer cocaine 
(COC), opiates and alcohol [14,15,17,18,30,47,48,49], a 
greater locomotor response to systemic cocaine [17], 
and a greater conditioned place preference to systemic 
morphine and COC [22], compared to F344 rats. In 
addition, delta-9-tetrahydrocannabinol facilitates in- 
tracranial self-stimulation in LEW rats, but not in 
Sprague-Dawley, Long Evans or F344 rats [12,13]. 
These studies have led some researchers to suggest 
that LEW rats may have a generalized vulnerability to 
the rewarding effects of addictive drugs [16,37]. 
The neurobiological basis for these behavioral dif- 
ferences between LEW and F344 rats is not known. 
Since the rewarding properties of many addictive drugs 
are thought to be mediated, in part, by the mesolimbic 
dopamine (DA) system [52], strain differences in the 
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behavioral responses to these drugs may be related to 
strain differences in DA neurotransmission. In support 
of this idea, Nestler and his colleagues have identified 
a number of regionally-specific biochemical differences 
in the nucleus accumbens and ventral tegmental area 
(VTA) between these two strains, including differences 
in levels of tyrosine hydroxylase, neurofilament pro- 
teins, adenylate cyclase, cyclic AMP-dependent protein 
kinase, G-proteins and glial fibrillary acidic protein 
[2-4,22,23]. On the other hand, there is no difference 
between LEW and F344 rats in striatal D1, D2 or 
mazindol binding [19], or in the expression, transcrip- 
tion and genomic organization of striatal D2 receptors 
[31], so it is not clear whether these strains differ in the 
effects of addictive drugs on DA neurotransmission. 
Since a common feature of many addictive drugs is 
their ability to increase the extracellular concentration 
of DA in the nucleus accumbens [10], we hypothesized 
that addictive drugs may affect DA neurotransmission 
differently in LEW and F344 rats by differentially 
elevating extracellular DA. Thus, the major purpose of 
the present study was to test this hypothesis. We did so 
by comparing the effects of an acute systemic injection 
of methamphetamine (mAMP) or COC on the extra- 
cellular concentration of DA in the nucleus accumbens 
in LEW and F344 rats, using in vivo microdialysis in 
awake freely moving animals. In addition, we charac- 
terized the behavioral response to repeated mAMP 
injections (i.e. sensitization) in LEW and F344 rats, 
and tested for strain differences in drug pharmacoki- 
netics. 
2. Materials and methods 
2.1. Experiment 1: The effects of  mAMP or COC on motor behavior 
and extracellular dopamine in L E W  and F344 rats 
2.1.1. Subjects 
Subjects were male F344 and LEW rats (Harlan, Indianapolis, 
IN) of the same age (9-10 weeks) and weighing 180-240 g and 
220-270 g, respectively, at the beginning of the experiment.  Animals  
were housed individually in wire-hanging cages in a light (14:10 
l ight:dark cycle, lights on at 06:00 h) and temperature  (68-74°C) 
controlled room with food and water continuously available. For the 
first experiment,  which will be referred to as the mAMP experiment, 
each of the two strains was divided into two groups. One group 
received an injection of 0.5 m g / k g  me thamphe tamine  sulfate 
(mAMP)  during the first dialysis test session and 2.0 m g / k g  m A M P  
during a second test session, one week later. The second group 
received 1.0 m g / k g  m A M P  during the first test session and 4.0 
m g / k g  m A M P  during the second test session. In the second experi- 
ment,  which will be referred to as the COC experiment, one group 
received an injection of 5.0 m g / k g  cocaine-HCl (COC) during test 
session one and 15 m g / k g  C OC  during test session two. A second 
group received 10 m g / k g  C OC  during test session one and 30 m g / k g  
COC during the second test session. Thus,  in each experiment  every 
rat was tested twice using two different doses of either m A M P  or 
COC (with the smaller of  the two doses always given during the first 
test session). Different hemispheres  were used for the two dialysis 
test sessions, and right and left sides were randomized across test 
sessions. During a given test session equal or nearly equal numbers  
of F344 and LEW rats were tested (typically 5 LEW and 5 F344 rats 
were tested together), and rats were randomized across the different 
test chambers.  All drug doses are expressed as the weight of the salt, 
and drugs were dissolved in 1.0 m g / m l  of 0.9% saline and adminis- 
tered intraperitoneally. Finally, the m A M P  experiment was com- 
pleted prior to the start of the COC experiment.  
2.1.2. Surgical procedures 
Following one week of habituation to the animal room and to 
being handled, animals were pretreated with atropine methyl nitrate 
(5 mg /kg ,  i.p.), anesthetized with sodium pentobarbital  (30-50 
mg /kg ,  i.p.), supplemented with methoxyflurane as necessary, and 
using s tandard stereotaxic procedures 21-gauge stainless steel guide 
cannulae were placed on the dural surface above each nucleus 
accumbens and fixed in place with dental  cement  and jeweler's 
screws attached to the skull. The coordinates were: (for F344 rats) 
anterior to bregma, 1.2-1.8 mm; lateral, 1.1-1.6 ram; and ventral, 1.0 
m m  from the skull surface; (for LEW rats) anterior, 2.4-2.7 mm; 
lateral, 1.4-1.6 mm; and ventral, 1.0 mm [39]. In addition, a 10-12 
mm piece of 17-gauge stainless steel tubing with a 90 ° bend at the 
lower end was positioned in the dental  cement  about 5 mm posterior 
to the guide cannulae to be later used to attach the animal to a 
tether.  
After  implantation of the guide cannulae all rats were castrated. 
This was done because circulating testicular hormones  are known to 
influence the behavioral response to psychomotor st imulant  drugs 
[1,7], in part because of their effect on drug metabolism [27], and we 
wanted to eliminate the possibility that pharmacokinetic factors due 
to strain differences in circulating levels of gonadal hormones  would 
influence the results. 
2.1.3. Microdialysis procedures 
One week following surgery rats were lightly anesthetized using 
e ther  and methoxyflurane, and a single microdialysis probe was 
lowered into either the right or left nucleus accumbens via a guide 
cannula. The concentric-shaped dialysis probe was basically as de- 
scribed by Robinson and Camp [41], with a few modifications. Both 
the inlet and outlet lines consisted of fused silica, and the length of 
dialysis membrane  (250 ~ m  O.D.) extended from the bot tom of the 
guide cannula to the ventral tip of  the probe. The dialysis membrane  
was coated with cyanoacrylate glue (Cyanodent Fast, Ellman Inter- 
national, Hewlett, NY), except for the most  ventral 2 mm at its tip 
(i.e. the dialysis surface was 2 m m  long). After  the probe was lowered 
into the nucleus accumbens,  the animal was placed into a 46 × 27 × 
28.5 cm oval-shaped Plexiglas chamber.  The  animal was connected to 
a liquid swivel (Instech) via a steel tether (model airplane cable) 
fastened to the piece of stainless steel tubing that protuded from the 
back of the dental  cement  'cap'  on the animal 's  head. The animals 
were then left undisturbed overnight, and food and water were freely 
available in the dialysis chambers.  The  perfusion solution consisted 
of 145 mM NaCI, 2.7 mM KCI, 1.2 mM CaCI 2, 1.0 mM MgCI 2 and 
0.2 mM ascorbic acid, pH 7.3 [35], and it was pumped through the 
probe overnight at 0 .3 /x l /min .  
The next morning the first test session commenced.  The  pump 
was turned up to 1.5 p , l /min  and after a 1.5-2 h equilibration period 
three 20 min 'baseline '  samples of  dialysate were collected. Follow- 
ing collection of baseline samples, the animals received 1 m l / k g  of 
0.9% saline, and three 20 min 'saline'  samples were collected. 
Immediately following collection of the last saline sample all animals 
received an injection of m A M P  or COC, and eight additional 20 min 
samples were collected. After  the last of these samples had been 
collected the dialysis probe was removed, the stylet replaced, and the 
animals were re turned to their home cage. A second test session was 
conducted one week later using the same procedures as described 
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above, and the same animals, but a dialysis probe was placed in the 
contralateral nucleus accumbens. Dialysate samples were assayed for 
DA, DOPAC, 5-HIAA and HVA by HPLC with electrochemical 
detection using procedures similar to those described previously [41]. 
2.1.4. Measurement of  motor behavior 
Response to a novel environment. Prior to the first dialysis test 
session all rats were placed into the test chambers described above, 
and two measures of motor behavior were acquired over 5 min 
intervals for 1 h. Movement from one side of the long axis of the 
cage to the other (crossovers) was detected using two photocells 
placed 23.5 cm apart and 4.5 cm above the cage floor. A single count 
was registered when the animal crossed the photocell beam, and 
another count from that photocell could not be registered until the 
other photocell beam was broken. An estimate of rearing behavior 
was obtained using four photocells positioned near the four corners 
of the chambers and 13.5 cm above the cage floor. 
mAMP and COC tests. Crossovers and rearing were also recorded, 
as described above, for 60 min following an injection of saline and 
for 160 min following the administration of mAMP or COC. In 
addition, following drug administration every animal was videotaped, 
and the videotapes later were used to visually rate drug-induced 
behavior using a 9-point scale adapted from Ellinwood and Balster 
[11]. On this scale, l=asleep;  2=  inactive; 3=normal in place 
activity; 4 = normal, alert, active; 5 = hyperactive; 6 = slow patterned 
stereotyped behavior; 7 = fast patterned stereotyped behavior; 8 = 
restricted stereotyped behavior; and 9 = dyskinetic-reactive behavior. 
Behavior was rated during a 30 s period every 10 min following the 
mAMP or COC injection for 160 min by a person blind to the 
experimental condition. In addition, the number of rears (defined as 
both forepaws elevated) occurring during each of these 30 s periods 
was also recorded and used to validate the automated measurement 
of rearing. The correlation between the automated and visual mea- 
surements of rearing was r = 0.89. 
2.1.5. Sensitization 
A separate behavioral experiment using independent groups of 
animals (i.e. they were not used in the dialysis experiments) was 
conducted to determine whether repeated intermittent treatment 
with mAMP produced comparable behavioral sensitization in LEW 
and F344 rats. For this experiment castrated male rats were placed 
into the test chambers described above, and after a 1 h habituation 
period they received an injection of either saline or 2.0 mg/kg of 
mAMP (n =9-10/group),  and behavior recorded (as described 
above) for an additional 160 min. This procedure was repeated every 
3-4 days for a total of 5 injections. During a final sixth test session, 
3-4 days after the fifth, all animals (both saline and mAMP pre- 
treated) received 2.0 mg/kg of mAMP. 
in the COC experiment 2 LEW and 7 F344 rats were excluded from 
the analyses of the effect of COC on DA because of chromatography 
problems. For simplicity, the final group n values for each statistical 
analysis are listed in the figure legends along with the summaries of 
the statistical tests. Finally, data for the mAMP- and COC-treated 
animals were analyzed separately because these groups were tested 
at different points in time, approximately one year apart. 
In vitro recovery was performed on all dialysis probes prior to 
each use, and dialysate values reported here were corrected for 
recovery. The average ( _+ S.E.M.) recovery values for probes used in 
the mAMP experiment were: DA, 14.48±0.65% and 14.45_+0.73% 
for LEW (n = 37) and F344 (n = 31) rats, respectively; DOPAC, 
12.06+0.58% and 12.42_+0.63%; HVA, 11.39+0.52% and 11.61_+ 
0.58%; 5-HIAA, 12.39 + 0.58% and 12.56 + 0.63%. The recovery val- 
ues did not differ significantly between strains. For the COC experi- 
ment recovery values were: DA, 16.13_+0.35% and 14.92_+0.38% 
(n = 49 and 57); DOPAC, 13.80_+0.31 and 12.68-+0.38; HVA, 13.36 
_+0.29 and 12.24-+0.34; 5-HIAA, 14.52-+0.36 and 13.27_+0.37. The 
recovery values were significantly higher for LEW rats, compared to 
F344 rats (P < 0.05). 
2.2. Experiment 2." mAMP and COC pharmacokinetics 
Male LEW and F344 rats were obtained and housed as described 
in Experiment 1. After one week, all rats were castrated under 
general anesthesia (as described above). One week later each rat was 
given a single i.p. injection of either 2.0 mg/kg mAMP (weight of the 
salt) or 10 mg/kg COC (weight of the salt), and returned to its home 
cage. At 40, 80 (COC animals only) or 120 (mAMP animals only) min 
later, animals were decapitated, and trunk blood and brains were 
obtained for determination of mAMP, amphetamine or COC con- 
centrations. Blood was immediately centrifuged at 3,000-5,000 rpm 
for 10 min at 4°C, and one ml of plasma was transferred to a test 
tube and immediately frozen at -20°C. The brain was rinsed with 
ice cold saline, and then placed into a chilled cutting block. A 3 mm 
coronal slice corresponding to sections 2 and 3, as described by 
Heffner et al. [24], was used to generate the brain tissue sample. The 
tissue was weighed and then homogenized in 1 ml of ice cold 
HPLC-grade water. These samples were immediately frozen at 
-20°C until assayed. Standards were prepared by adding known 
amounts of drug to the plasma or brain homogenates from nonin- 
jected animals. It should be noted that the blood and brain samples 
to be assayed for COC levels were prepared in 1% sodium fluoride 
to inhibit cocaine degradation [5]. Determination of drug concentra- 
tions in these samples was performed by the Center for Human 
Toxicology, University of Utah, using gas chromatography coupled to 
positive ion chemical ionization mass spectrometry, with quantitation 
in the selected ion monitoring mode. 
2.1.6. Histological verification of probe placement 
Upon completion of the second dialysis test session each animal 
was perfused through the heart with 0.9% saline followed by 10% 
formalin in saline, its brain removed, and stored in 10% formalin in 
saline. The brains were sectioned and stained with Cresyl violet, and 
examined to determine the exact location of each dialysis probe. 
2.1.7. Data analyses 
The behavioral rating scores were analyzed using nonparametric 
statistics, including Profile analyses [36] and, if significant, subse- 
quent Mann-Whitney U-tests. Crossovers, rearing, and the neuro- 
chemical data were analyzed using parametric statistics, including 
one- or two-way analyses of variance and, if significant, subsequent 
Fisher's PLSD post hoc tests or Student's t tests for planned compar- 
isons. Because of equipment malfunctions (e.g. microcomputer, vide- 
orecorders, or chromatography) group n values for the behavioral 
and neurochemical measurements sometimes differed. For example, 
3. Results 
3.1 B e h a v i o r  
3.1.1. R e s p o n s e  to a n o v e l  e n v i r o n m e n t  
Fig.  1 s h o w s  t h e  t i m e  c o u r s e  o f  m o t o r  act ivi ty (c ros -  
sover s  a n d  r e a r i n g )  fo l l owing  p l a c e m e n t  in a nove l  
e n v i r o n m e n t  in L E W  a n d  F344  ra t s  t e s t e d  in t h e  C O C  
e x p e r i m e n t .  A l t h o u g h  t h e  d i f f e r e n c e s  w e r e  smal l ,  L E W  
ra t s  s h o w e d  s ign i f i can t ly  m o r e  m o t o r  act ivi ty in re -  
s p o n s e  to  a nove l  e n v i r o n m e n t  t h a n  F344  ra t s  ( s ee  
f i gu re  c a p t i o n s  fo r  s u m m a r i e s  o f  t h e  s ta t i s t i ca l  ana ly-  
ses) .  T h e  s a m e  e f f ec t  was  f o u n d  in t h e  m A M P  expe r i -  
m e n t  ( d a t a  n o t  s h o w n ) .  
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3.1.2. Dose-effect curves for mAMP and COC 
Strain differences in the psychomotor activating ef- 
fects of mAMP and COC were assessed using three 
different behavioral measures - a visual rating scale, 
crossovers and rearing. COC did not produce focussed, 
in place, stereotyped behavior (i.e. a rating score of 8) 
at any of the four doses tested, and therefore, ratings 
were not analyzed for the COC-treated animals. Fig. 2 
shows the mAMP dose-effect  curves for LEW and 
F344 rats based on the behavioral rating scores. LEW 
rats showed significantly greater behavioral activation 
to mAMP than F344 rats, as indicated by a significant 
shift to the left in their dose-effect  curve. Further 
analyses of the time course of the rating scores at each 
dose, shown in Fig. 3, indicated that the strain differ- 
ence was due primarily to a longer duration of action 
of mAMP in LEW rats, rather than to a difference in 
the peak effect of the drug (except at the 2.0 m g / k g  
dose, which produced a greater peak effect in LEW 
rats). 
Strain differences in the dose-effect  curves for 
mAMP and COC-induced locomotor activity (cros- 
sovers) are shown in panels I (insert) in Figs. 4 and 5. 
Locomotor activity increased with higher doses, except 
at the highest dose of mAMP tested. At 4.0 mg /kg  of 
mAMP locomotor activity decreased relative to that 
10 A .  B. 
T 12]Q 
2 a -  . 
F 
0 2 4 6 8 10 12 
5 min intervals 
Fig. 1. Crossovers from one side of the test chamber to the other 
(locomotor activity; Panel A) and the incidence of rearing behavior 
(Panel B, insert) of LEW (open circles) and F344 (closed circles) rats 
in response to a novel environment. Values represent means + S.E.M. 
LEW rats showed significantly greater spontaneous motor activity 
than F344 rats (two-way ANOVA's  with repeated measures on one 
factor). Crossovers - effect of strain, F = 25.7, P < 0.0001; effect of 
time, F = 78.5, P < 0.0001; strain x time interaction, F = 5.47, P < 
0.0001; Rears - effect of strain, F = 20.07, P < 0.0001; effect of time, 
F = 54.3, P < 0.0001; strain x t ime  interaction, F = 3.86, P < 0.0001. 
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Fig. 2. The mean ( +  S.E.M.) behavioral rating scores averaged over 
160 min following an injection of 0.5, 1.0, 2.0 or 4.0 mg /kg  of 
mAMP. LEW rats (open circles) showed a significant shift to the left 
in the dose-effect curve, compared to F344 rats (closed circles). 
Mann-Whitney U-tests were performed comparing LEW and F344 
rats at each dose: 0.5 mg/kg,  U = 63, P = 0.04; 1.0 mg/kg,  U = 27.5, 
P =  0.0007; 2.0 mg/kg,  U =  0, P <0.0001; 4.0 mg/kg,  U =  16.5, 
P = 0.015. Group n values: 0.5 mg/kg,  LEW n = 15, F344 n = 15; 1.0 
mg/kg,  LEW n = 15, F344 n = 14; 2.0 mg/kg,  LEW n = 13, F344 
n = 12; 4.0 mg/kg,  LEW n = 12, F344 n = 8. 
seen following 2.0 m g / k g  mAMP. This decrease oc- 
curred because animals were engaged in stereotyped 
behavior (as described above; also see Fig. 3). Al- 
though there was no significant strain difference in the 
mAMP dose-effect  curves, the time course of mAMP- 
induced locomotor activity at each dose, shown in 
panels A, C, E and G in Fig. 4, clearly showed that the 
pattern of locomotor activity differed between the two 
strains. LEW rats showed a more sustained increase in 
locomotor activity than F344 rats at the two lower 
doses of mAMP, and at the 4.0 m g / k g  dose of mAMP 
showed a more sustained stereotypy phase than F344 
rats, as indicated by the absence of any locomotor 
activity at the end of the test session. LEW rats also 
showed a more sustained increase in COC-induced 
locomotor activity, but only following 10 m g /k g  and 30 
m g /k g  of COC (see panels A, C, E, G and I in Fig. 5). 
The pattern of strain differences for mAMP- and 
COC-induced rearing was similar to that described 
above for crossovers. As shown in panels B, D, F, and 
H of Figs. 4 and 5, LEW rats generally exhibited a 
longer duration of enhanced rearing following an injec- 
tion of mAMP or COC than F344 rats. At a mAMP 
dose of 4.0 m g / k g  LEW rats exhibited less rearing 
than F344 rats, and this was due to LEW rats engaging 
in focussed, in place, stereotypy. 
184 D.M. C a m p  et al. / Brain Research 668 (1994) 180-193  
3.1.3. Sensitization 
Fig. 6 shows behavioral activity ratings for LEW and 
F344 rats following each of five successive injections of 
mAMP, and then also after a sixth injection, when both 
saline- and mAMP-pretreated animals received a 
mAMP 'challenge'. Fig. 6 shows that mAMP produced 
a greater behavioral effect in LEW rats, relative to 
F344 rats, even during the first test session, consistent 
with the dose-effect  analysis described above. In addi- 
tion, both LEW and F344 rats showed a significant 
increase in ratings between the first and fifth test 
sessions, and in both strains mAMP-pretreated animals 
had significantly higher ratings than saline-pretreated 
animals on the 'challenge' test day. Thus, both strains 
showed sensitization to the behavioral activating ef- 
fects of mAMP. 
Sensitization was also evident upon examination of 
the automated measure of locomotor activity ('cros- 
sovers'), although the pattern of change was quite 
different in LEW and F344 rats (data not shown). The 
F344 rats showed primarily locomotor hyperactivity 
(without stereotyped sniffing and head movements) 
during the first test session, and even greater locomo- 
tor hyperactivity by the sixth test session (but still not 
much stereotyped behavior). In contrast, during the 
first test session LEW rats showed comparable locomo- 
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Fig. 3. The mean ( + S.E.M.) behavioral rating scores during each ten 
minute interval for 160 min following an injection of 0.5, 1.0, 2.0 or 
4.0 mg/kg  of mAMP in LEW (left panel) and F344 (right panel) rats. 
Profile analyses were performed comparing LEW and F344 rats at 
each dose: 0.5 mg/kg,  effect of strain, F = 5.87, P = 0.022, effect of 
time, F=8 .66 ,  P<0.0001,  parallelism, F=2 .27 ,  P=0.066;  1.0 
mg/kg,  effect of strain, F = 16.29, P = 0.0004, effect of time, F = 
2.69, P = 0.04, parallelism, F = 2.66, P = 0.04; 2.0 mg/kg,  effect of 
strain, F = 79.3, P < 0.0001, effect of time, F = 3.55, P = 0.038, 
parallelism, F = 3.07, P = 0.057; 4.0 mg/kg,  a Profile analysis could 
not be performed because there was no variability for some of the 
intervals in LEW rats (i.e. all LEW rats had a behavioral rating score 
of 8 during the last four 10 min intervals, whereas only 1-3 F344 rats 
had a score of 8 during this same time period). Group n values are 
the same as in Fig. 2. Subsequent Mann-Whitney U-tests at each 10 
min interval were performed to determine at which times LEW and 
F344 rats differed (P  < 0.05), and these times are indicated by the 
asterisks. 
difference in the number of 'crossovers'), although in 
LEW rats this was accompanied by stereotyped sniffing 
and head movements. By the sixth test session LEW 
animals made very few crossovers because they were 
engaged primarily in focussed stereotyped behavior 
(Fig. 6). Thus, with this dose of mAMP, sensitization in 
F344 rats was characterized by a shift from locomotor 
hyperactivity to greater locomotor hyperactivity, 
whereas in LEW rats sensitization was characterized by 
a shift from locomotor hyperactivity (with stereotyped 
sniffing and head movements) to focussed, in place, 
stereotyped behavior. 
It is very difficult, however, to directly compare the 
rate of sensitization in LEW vs. F344 rats using the 
data presented in Fig. 6, because the two groups dif- 
fered so much on the first test day, and because of the 
nature of ordinal scales. In an attempt to control for 
this variable the LEW and F344 groups were divided 
into two subgroups that did not differ in their acute 
response to mAMP. This was done by dividing the 
groups into those above (high) or below (low) the 
median on the first test session. The smaller symbols 
connected with dashed lines plotted in Fig. 6 show that 
there was no difference between LEW (low) and F344 
(high) subgroups on the first test session, but a marked 
difference by the fifth test session, consistent with the 
conclusion that LEW animals showed greater sensitiz- 
tion than F344 animals, even after controlling for strain 
differences in acute drug response. 
3.2. Dialysis 
3.2.1. Dialysis probe placements 
Fig. 7 shows the location of the dialysis surface of 
probes in the ventral striatum for all mAMP- and 
COC-treated animals for which neurochemical data 
were used. Animals with unacceptable probe place- 
ments were excluded from the neurochemical analyses, 
and their placements are not shown. As can be seen, 
there was considerable variability in probe placements 
within the ventral striatum. Some probes extended 
dorsally into the caudate nucleus and others ventrally 
into the olfactory tubercle, but most were centered in 
the region of the nucleus accumbens. Most impor- 
tantly, however, there was considerable overlap in 
placements between LEW and F344 rats. To determine 
whether there was a statistical difference in the loca- 
tions of probe placements between F344 and LEW 
rats, the ventral striatum was subdivided into three 
equal regions along each of the following planes: ante- 
rior-posterior (A-P), medial-lateral (M-L) and dorsal- 
ventral (D-V), and chi-square analyses were performed 
on the number of rats in each strain with placements in 
each of these three regions. There was no significant 
strain difference in probe placements in any dimen- 
sion, except in one case. In the COC experiment, there 
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were significantly more LEW rats with relatively ven- 
tral placements (34.0% vs. 8.0%), and more F344 rats 
with dorsal (22.0% vs. 10.6%) and middle (70.0% vs. 
55.3%) placements (g  2 statistic = 8.78, P = 0.012). 
3.2.2. Basal extracellular concentrations of DA and 
metabolites 
The mean basal extracellular concentrations of DA, 
DOPAC, H VA and 5-HIAA in LEW and F344 rats are 
shown in Fig. 8, with mAMP-treated animals repre- 
sented in Panel A and COC-treated animals in Panel 
B. Consistent with Strecker et al. [46], the basal extra- 
cellular concentration of D A  was slightly lower in 
LEW rats compared to F344 rats, but this difference 
was not statistically significant in either the mAMP- or 
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DOPAC and HVA, were significantly lower in LEW 
rats. (For COC animals, both DOPAC and HVA were 
significantly lower in LEW rats, but for mAMP animals 
the difference was statistically significant only for 
HVA.) In contrast to the DA metabolites, the extracel- 
lular concentration of the serotonin metabolite, 5- 
HIAA, did not significantly differ between the two 
strains. 
3.2.3. Dose-effect for mAMP and COC 
Fig. 9 shows the extracellular concentration of DA, 
expressed as a percent of baseline, averaged over the 
entire 160 min collection period following an injection 
of mAMP (panel A) or COC (panel B) in LEW and 
F344 rats. Both drugs produced a dose-dependent in- 
crease in the extracellular concentration of DA, but 
this increase was significantly greater in LEW rats 
relative to F344 rats, as indicated by a significant shift 
to the left in the dose-effect  curve for LEW rats. 
Further analyses of the time course of mAMP-stimu- 
lated DA release at each dose showed that the greater 
Fig. 4. The mean number of crossovers (panels A, C, E, and G) and 
rears (panels B, D, F, and H) per five min interval for 160 rain 
following an injection of 0.5, 1.0, 2.0 or 4.0 mg/kg  of mAMP in LEW 
(open circles) and F344 (closed circles) rats. Two-way ANOVA's  with 
one repeated measure showed a significant effect of time at each 
dose (F ' s  range from 3.6-17.1, all P ' s  < 0.0001; except rears at 4.0 
mg/kg,  F = 1.57, P = 0.026). There were significant strain differ- 
ences at some doses, but not others. Analyses of Crossovers: 0.5 
mg/kg,  effect of strain, F = 1.08, P = 0.31, strain x time interaction, 
F = 1.87, P = 0.003; 1.0 mg/kg,  effect of strain, F = 4.13, P = 0.051, 
strain X time interaction, F = 2.31, P < 0.0001; 2.0 mg/kg,  effect of 
strain, F = 0.78, P = 0.38, strain x t ime  interaction, F = 1.36, P = 
0.093; 4.0 mg/kg,  effect of strain, F = 2.34, P = 0.139, strain × time 
interaction, F =  3.94, P < 0.0001. Analyses of Rears: 0.5 mg/kg,  
effect of strain, F = 3.02, P = 0.09, strain x time interaction, F = 0.79, 
P = 0.79; 1.0 mg/kg,  effect of strain, F = 5.32, P = 0.028, strain x 
time interaction, F = 2.38, P < 0.0001; 2.0 mg/kg,  effect of strain, 
F = 3.02, P = 0.094, strain x t ime interaction, F = 1.80, P = 0.005; 
4.0 mg/kg,  effect of strain, F = 4.46, P = 0.045, strain x time interac- 
tion, F = 2.39, P < 0.0001. When the overall ANOVA showed a 
significant interaction effect, subsequent unpaired Student's t-tests 
(two-tailed) at each point in time after mAMP were performed to 
determine at which times the groups differed (P  < 0.05), and these 
times are indicated by the asterisks. Panel inserts (dose-effect curces): 
the mean (_+ S.E.M.) number of crossovers (panel I) and rears (panel 
J) recorded by the microcomputer and cumulated over the 160 min 
following an injection of 0.5, 1.0, 2.0 or 4.0 mg /kg  of mAMP. A 
two-way ANOVA performed on the crossover data showed a signifi- 
cant effect of dose (F  = 9.2, P < 0.0001), but no significant effects of 
strain (F=2 .15 ,  P=0.14) ,  or dose x strain interaction (F=2 .03 ,  
P = 0.11). A two-way ANOVA performed on the rearing data showed 
significant effects of strain (F  = 5.39, P = 0.02), dose (F  = 6.5, P = 
0.0004) and strain × dose interaction (F  = 2.79, P = 0.04). The aster- 
isks indicate that LEW rats showed greater rearing at 1.0 mg/kg  of 
mAMP, and less rearing at 4.0 mg/kg  of mAMP, relative to F344 
rats (unpaired Student's t-tests, P < 0.05). Group n values: 0.5 
mg/kg,  LEW n = 16, F344 n = 20; 1.0 mg/kg,  LEW n = 18, F344 
n = 1 4 ;  2.0 mg/kg,  LEW n = 1 4 ,  F344 n = 1 4 ;  4.0 mg/kg,  LEW 
n = 16, F344 n = 10. 
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response observed in LEW rats, relative to F344 rats, 
was due largely to LEW rats displaying a more pro- 
longed elevation in extracellular DA (see Fig. 10). 
Although analyses of the time course of the effect of 
COC on extracellular DA at each dose were highly 
significant for the effect of time, only the 10 mg/kg  
dose of COC resulted in a significant strain difference 
(LEW > F344; see Fig. 11). 
The extracellular concentrations of DOPAC, HVA 
and 5-HIAA following mAMP and COC were also 
determined (data not shown). As expected, mAMP 
decreased DOPAC and HVA concentrations at all 
doses tested. In addition, there were significant strain 
differences in the effect of mAMP on both DA 
metabolites, when the data were expressed as a per- 
cent of the basal values. DOPAC and HVA declined to 
a greater extent in LEW rats compared to F344 rats. 
At the two lower doses, the magnitude as well as the 
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duration of the decline was greater in LEW rats. At 
the two higher doses, the magnitude of the decline was 
similar between the strains, probably due to a floor 
effect, but the duration of the decline was still greater 
in LEW rats. In contrast, mAMP produced a small 
increase ( ~  115% of basal) in the extracellular concen- 
tration of 5-HIAA which was significantly greater in 
F344 rats compared to LEW rats following mAMP 
doses of 0.5, 1.0 and 2.0 mg/kg,  but not 4.0 mg/kg.  
The extracellular concentrations of DOPAC, HVA and 
5-HIAA following COC were also determined (data 
not shown). Consistent with previous reports [25,26,38], 
COC had very little effect on the DA metabolite levels, 
relative to the changes seen following mAMP. For 
example, DOPAC concentrations decreased to about 
75-85% of baseline values, and HVA decreased to an 
even lesser extent. Furthermore, these effects were not 
dose-dependent. 5-HIAA concentrations showed no 
change or a slight increase following COC. Following 
COC there were no consistent strain differences in any 
of the three metabolites measured. 
Fig. 5. The  m e a n  n u m b e r  of crossovers  (pane ls  A,  C, E, and  G) and 
rears  (panels  B, D, F, and  H)  pe r  five rain in terval  for 160 min  
fol lowing an inject ion of 5, 10, 15 or 30 m g / k g  of  coca ine  in L E W  
(open  circles)  and  F344 (closed circles)  rats.  Two-way A N O V A ' s  with 
one  r epea t ed  measu re  showed a s ignif icant  effect  of t ime  at  each  
dose  ( F ' s  r ange  from 3.5-26.9,  all  P ' s  < 0.0001). The re  were  signifi- 
cant  s t ra in  d i f ferences  at some doses,  but  not  others .  Ana lyses  of  
Crossovers:  5 m g / k g ,  effect  of s train,  F = 1.32, P = 0.26, s t ra in  X t ime  
in terac t ion ,  F = 1.37, P = 0.086; 10 m g / k g ,  effect  of  strain,  F = 7.30, 
P = 0.009, s t ra in  X t ime  in terac t ion ,  F = 2.88, P < 0.0001; 15 m g / k g ,  
effect  of strain,  F = 0.17, P = 0.68, s t ra in  x t ime in terac t ion ,  F = 1.40, 
P = 0.073; 30 m g / k g ,  effect  of s train,  F = 10.8, P = 0.002, s t ra in  x 
t ime in terac t ion ,  F = 3.35, P < 0.0001. Ana lyses  of Rears :  5 m g / k g ,  
effect  of  s train,  F = 3.74, P = 0.059, s t ra in  X t ime  in terac t ion ,  F = 
1.51, P = 0.037; 10 m g / k g ,  effect  of strain,  F = 15.5, P = 0.0002, 
s t ra in  x t ime  in terac t ion ,  F = 3.41, P < 0.0001; 15 m g / k g ,  effect  of 
s train,  F = 0.08, P = 0.78, s t ra in  x t ime  in terac t ion ,  F = 2.64, P < 
0.0001; 30 m g / k g ,  effect  of s train,  F = 0.00, P = 0.99, s t ra in  x t ime  
in terac t ion ,  F = 4.74, P < 0.0001. W h e n  the overal l  A N O V A  showed 
a s ignif icant  in te rac t ion  effect, subsequen t  u n p a i r e d  S tuden t ' s  t - tests  
( two-ta i led)  at each  point  in t ime af ter  m A M P  were  pe r fo rmed  to 
d e t e r m i n e  at  which t imes  the g roups  di f fered ( P  < 0.05), and  these  
t imes  are ind ica ted  by the asterisks.  Panel inserts (dose-effect 
curves): the  m e a n  (_+S.E.M.) n u m b e r  of crossovers  (panel  I) and 
rears  (panel  J) cumula t ed  over  the 160 rain fol lowing an inject ion of 
5, 10, 15 or 30 m g / k g  of cocaine.  A two-way A N O V A  pe r fo rmed  on 
the crossover  da ta  showed s ignif icant  effects  of s t ra in  ( F  = 13.43, 
P < 0.0001), dose  ( F  = 39.64, P < 0.0001) and  s t ra in  X dose  in terac-  
t ion ( F =  6.91, P = 0.0001). The  as ter isks  indica te  tha t  L E W  rats 
showed a g r ea t e r  locomotor  response  to 10 and 30 m g / k g  cocaine,  
c o m p a r e d  to F344 rats  ( unpa i r ed  S tuden t ' s  t tests,  P < 0.01). A 
two-way A.NOVA per fo rmed  on the rea r ing  da ta  showed a signifi- 
cant  effect  of  dose  ( F  = 20.7, P < 0.0001), but  no s ignif icant  s t ra in  
( F  = 1.67, P = 0.20) or in te rac t ion  effects  ( F  = 0.84, P = 0.47). G r o u p  
n values:  5 m g / k g ,  L E W  n = 20, F344 n = 27; 10 m g / k g ,  L E W  
n = 30, F344 n = 30; 15 m g / k g ,  L E W  n = 18, F344 n = 25; 30 m g / k g ,  
L E W  n = 26, F344 n = 30. 
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3.3. mAMP and COC pharmacokinetics 
Table 1 shows the brain and plasma concentrations 
of mAMP, AMP and COC in LEW and F344 rats. 
Forty min after the injection of mAMP, LEW rats had 
significantly higher (about 2-fold) brain and plasma 
concentrations of mAMP relative to F344 rats. At 120 
min, the strain difference was even greater, with the 
concentration of mAMP being about 3-fold higher in 
LEW than in F344 rats. AMP concentrations were 
much lower than mAMP levels, as expected. However, 
strain differences were present in AMP concentrations 
at both time points (LEW > F344). Interestingly, brain 
and plasma levels of AMP were actually higher at 120 
min than at 40 min in LEW rats, but in F344 rats the 
opposite was true (i.e. a two-way A N O V A  showed a 
significant strain × time interaction effect, F = 24.4, P 
< 0.0001). 
Although brain and plasma concentrations of COC 
were 2-to-3-fold higher at 40 min in LEW rats, relative 
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Fig. 6. The mean (+ S.E.M.) behavioral rating scores averaged over 
60 min in LEW (open circles) and F344 (closed circles) rats that 
received a total of 6 injections of mAMP (i.e. test sessions 1-6), and 
in saline-pretreated LEW (open squares) and F344 (closed squares) 
rats that received a challenge injection of mAMP during the 6th test 
session. Both strains showed a significant increase in rating scores 
across the 5 sensitization sessions (Friedman test, P's < 0.0009). On 
the challenge session (i.e. 6th test session) mAMP-pretreated groups 
had significantly greater rating scores compared to their saline-pre- 
treated controls (U= 0-0.5, P < 0.0004). When mAMP-pretreated 
F344 and LEW rats were divided into two subgroups, those above 
and below the median score for the first test session, the first 
injection of mAMP did not behaviorally distinguish LEW low re- 
sponders and F344 high responders (U = 8, P = 0.75), but by the 5th 
injection LEW low responders had significantly higher ratings than 
F344 high responders (U = 0, P = 0.016; see small symbols plotted to 
the left of the 1st and 5th test sessions). Group n values: LEW, n = 9 
for both saline- and mAMP-pretreated groups; and F344, n = 10 for 
both saline- and mAMP-pretreated groups. 
to F344 rats, this difference was not statistically signifi- 
cant because of large between subject (within strain) 
variation (P  = 0.10-0.13; see Table 1). There was one 
LEW rat that had brain and plasma levels of COC 7 to 
8 times lower than the next lowest value in its group. If 
this animal is excluded from the analysis, then the 
difference between LEW and F344 rats is statistically 
significant (P  < 0.01). By 80 min post-injection, how- 
ever, there was no statistically significant strain differ- 
ence in either brain or plasma levels of COC (see 
Table 1). These results are consistent with an earlier 
preliminary study, in which we quantified the concen- 
tration of COC in dialysate obtained from the nucleus 
accumbens, at 20, 40 and 60 min following an injection 
of 30 m g / k g  COC, and found that the dialysate con- 
centration of COC was higher in LEW rats compared 
to F344 rats (at 20 min post-injection the concentration 
of COC in dialysate was 3.0 + 0.52 ng /20  /xl and 
1.58 + 0.32 ng /20 /z l  for LEW (n = 4) and F344 (n = 4) 
rats, respectively, t = 2.34, P = 0.06; at 40 min it was 
5.15 + 1.08 and 2.12 + 0.59 ng /20 /z l ,  respectively, t = 
2.46, P = 0.05; at 60 min it was 3.3 + 0.80 and 1.78 + 
0.13 ng /20 /z l ,  respectively, t = 1.88, P = 0.11). 
4. Discussion 
The present results extend the growing list of behav- 
ioral, biochemical [18,37] and neuroendocrinological 
[6,44] differences reported between LEW and F344 
rats. First, LEW rats were more sensitive to the psy- 
chomotor activating effects of both mAMP and COC, 
as indicated by a shift to the left in the dose-effect  
curves relative to F344 rats. Secondly, LEW rats were 
more susceptible to mAMP sensitization. Thirdly, LEW 
rats showed a greater increase in extracellular DA in 
the ventral striatum in response to mAMP and COC, 
as indicated by a shift to the left in the dose-effect  
curves relative to F344 rats. Furthermore, strain differ- 
ences in both the behavioral and neurochemical mea- 
sures reported here were primarily due to an increased 
duration of action of mAMP and COC in LEW rats. 
Finally, the neurobiological basis of these strain differ- 
ences is not established, but the results of Experiment 
2 suggest strain differences in drug pharmacokinetics 
may play an important role. 
4.1. L E W / F 3 4 4  differences in the behavioral effects of  
addictive drugs 
Although there have been a number of reports that 
the reinforcing effects of addictive drugs differ in LEW 
and F344 rats (see Introduction), there have been 
relatively few studies on strain differences in their 
psychomotor stimulant effects. George and his col- 
leagues [17,19] reported that LEW rats show greater 
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locomotor  activity in response to COC than  F344 rats, 
and this effect was repl icated here to the extent  that 
LEW rats displayed greater  locomotor  activity follow- 
ing both 10 m g / k g  and  30 m g / k g  of COC (al though 
compare  with [28]). In  contrast ,  George  et al. [19] 
repor ted  that  D-amphetamine  adminis te red  subcuta-  
neously produced greater  locomotor  s t imulat ion in 
F344 rats than in L E W  rats, whereas  in the present  
exper iment  L E W  rats were more  responsive to the 
psychomotor  activating effects of m A M P  than  F344 
rats. This apparen t  discrepancy may be due to differ- 
ences in the action of D-amphetamine  vs. mA MP ,  or in 
the route of drug adminis t ra t ion  ( subcutaneous  vs. 
in t raper i toneal) .  However,  a more  likely al ternat ive 
Fig. 7. Schematic representation of the location of the active surface of the dialysis probes in the ventral striatum in F344 and LEW rats. Panel A 
shows the location of probes (n = 31 for F344; 37 for LEW) for animals that received mAMP, and Panel B shows the location of probes (n = 57 
for F344 and 49 for LEW) for animals that received COC. In each case, the location of probes in F344 rats is shown in the left half of each 
section and in the right half of each section for LEW rats. The drawings are based on the atlas of Paxinos and Watson [39]. The number on each 
drawing indicates the distance anterior to bregma. 
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explanation involves the way the behavioral measures 
were obtained and analyzed. George et al. [19] re- 
ported dose-effect curves for cumulative locomotor 
activity scores based on only a 60 min test, and from 
these calculated EDs0 values. Although the EDs0 value 
for D-amphetamine-induced locomotor activity was 
greater for LEW than for F344 rats, LEW rats also 
exhibited greater maximal levels of D-amphetamine-in- 
duced locomotor activity. Furthermore, George et al. 
[19] did not provide data on the time course of D- 
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Fig. 8. The  m e a n  ( + S . E . M . )  basal  ex t race l lu la r  concen t r a t i ons  of  
d o p a m i n e  (DA),  d ihydroxyphenylace t ic  acid ( D O P A C ) ,  homovani l l i c  
acid ( H V A )  and  5-hydroxyindoleace t ic  acid ( 5 - H I A A )  m e a s u r e d  in 
the ven t ra l  s t r i a tum of  an ima l s  tha t  subsequen t ly  rece ived  an injec- 
t ion of  m A M P  (Pane l  A)  or  C O C  (Panel  B). Basal  va lues  r ep re sen t  
the ave rage  of  th ree  20 rain base l ine  samples .  T h e r e  were  no 
s ignif icant  d i f fe rences  be tween  L E W  and  F344 ra ts  in the basa l  
concen t r a t i ons  of  D A  ( m A M P  exper iment ,  t = 1.79, P = 0.077; C O C  
expt. ,  t = 1.17, P = 0.24) or  5 - H I A A  ( m A M P  expt.,  t = 1.79, P = 
0.077; C O C  expt.,  t = 0.28, P = 0.78). The re  were  s ignif icant  s t ra in  
d i f ferences  in the  basa l  concen t ra t ions  of  D O P A C  ( m A M P  expt.,  
t =  1.56, P = 0 . 1 2 4 ;  C O C  expt.,  t = 2 . 4 5 ,  P = 0 . 0 1 6 )  and  H V A  
( m A M P  expt. ,  t = 2.81, P = 0.006; C O C  expt.,  t = 5.94, P < 0.0001), 
as ind ica ted  by the  aster isks.  G r o u p  n values:  m A M P  exper imen t ,  
L E W  n = 37, F344 n = 31; Coca ine  expe r imen t ,  L E W  n = 47 (DA),  
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Fig. 9, The  m e a n  ( + S . E . M . )  ex t race l lu la r  concen t ra t ion  of  DA,  
expressed  as the  pe rcen t  of base l ine  ave raged  over  the en t i re  160 
min  per iod  fol lowing an inject ion of  m A M P  or  COC.  Pane l  A. 
m A M P :  A two-way A N O V A  showed s ignif icant  effects  of s t ra in  
( F  = 12.56, P = 0.0008) and  dose  ( F  = 74.9, P < 0.0001), bu t  no 
in te rac t ion  effect  ( F  = 2.03, P = 0.12). G r o u p  n values:  0.5 m g / k g ,  
L E W  n = 9, F344 n = 8; 1.0 m g / k g ,  L E W  n = 11, F344 n = 8 ;  2.0 
m g / k g ,  L E W  n = 8, F344 n = 7; 4.0 m g / k g ,  L E W  n = 9, F344 n = 8. 
Pane l  B. COC:  A two-way A N O V A  showed s ignif icant  effects  of  
s t ra in  ( F  = 4.33, P = 0.04) and  dose  ( F  = 45.6, P < 0.0001), bu t  no 
s t ra in  × dose  in te rac t ion  ( F  = 0.24). G r o u p  n values:  5 m g / k g ,  L E W  
n = 10, F344 n = 10; 10 m g / k g ,  L E W  n = 10, F344 n = 14; 15 m g / k g ,  
L E W  n = 13, F344 n = 12; 30 m g / k g ,  L E W  n = 14, F344 n = 14. 
ported here LEW and F344 rats exhibited very differ- 
ent temporal patterns of mAMP-induced locomotor 
activity, rearing and stereotyped behavior. Indeed, the 
most salient strain difference in drug-induced stereo- 
typy, locomotion and rearing was in the duration of the 
drug response, with LEW rats showing a more sus- 
tained behavioral response than F344 rats. LEW rats 
also are reported to show more prolonged morphine- 
and ethylketocyclazacine-induced EEG slow-wave 
bursts and associated behavioral stupor than F344 rats 
[33,34]. Thus, the difference between George et al. [19] 
and the present experiment may involve the reliance 
on cumulative photocell counts alone as an index of 
the psychomotor activating effects of amphetamine. 
For example, a comparison of the behavioral ratings 
shown in Figs. 2 and 3 with the photocell counts shown 
in Fig. 4 illustrate the difficulty in interpreting cumula- 
tive photocell counts. 
In addition to strain differences in the acute effects 
of mAMP and COC, LEW and F344 rats also differed 
in their response to repeated drug administration, with 
LEW rats showing greater behavioral sensitization to 
mAMP than F344 rats. Kosten et al. [28] recently 
reported a similar strain difference in cocaine sensiti- 
zation. Similarly, Mayo-Michelsen and Young [32] re- 
ported that LEW rats show greater tolerance to the 
behavioral stupor produced by chronic morphine treat- 
















I I  I I  I 
Basal Saline Amphetamine 
1.0 mg/kg 
I I  I I  
4.0 mg/kg 
L 
I I| II 
Basal Saline Amphetamine 









Fig. 10. The effects of 0.5, 1.0, 2.0 and 4.0 mg/kg  of mAMP on the 
mean (+S.E.M.) extracellular concentration of DA in LEW and 
F344 rats. The first three 20 min intervals represent the basal 
extracellular concentration of DA, the second three intervals repre- 
sent the extracellular concentration of DA following a saline injec- 
tion and each subsequent 20 min interval was obtained following the 
mAMP injection. Values are expressed as a percent of the average 
baseline value for each animal. Two-way ANOVA's  conducted over 
the 160 min after mAMP showed a significant effect of time for each 
dose (F ' s  range from 32 to 68, all P ' s  < 0.0001). In addition, there 
were significant differences in response to mAMP between LEW and 
F344 rats (0.5 mg/kg,  effect of strain, F = 6.35, P = 0.024, strain × 
time interaction, F = 0.94, P = 0.49; 1.0 mg/kg,  effect of strain, 
F = 3.05, P = 0.099, s train×time interation, F = 0.93; 2.0 mg/kg,  
effect of strain, F = 4.31, P = 0.058, strain x time interaction, F = 
2.14, P = 0.047; 4.0 mg/kg,  effect of strain, F = 4.32, P = 0.055, 
strain x time interaction, F = 9.55, P < 0.0001). Group n values are 
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Fig. 11. The effects of 5, 10, 15 and 30 mg/kg  of COC on the mean 
( _+ S.E.M.) extracellu]ar concentration of D A  in LEW and F344 rats. 
The first three 20 min intervals represent the basal extracellular 
concentration of DA, the second three intervals represent the extra- 
cellular concentration of DA following a saline injection and each 
subsequent 20 min interval was obtained following the COC injec- 
tion. Values are expressed as a percent of the average baseline value 
for each animal. Two-way ANOVA's  conducted over the 160 min 
after COC showed a significant effect of time for each dose (F ' s  
range from 16.8 to 67.9, all P 's  < 0.0001). In addition, the extracellu- 
lar concentration of DA was enhanced to a greater extent in LEW 
rats compared to F344 rats following 10 mg/kg  cocaine (effect of 
strain, F = 5.77, P = 0.025, interaction effect, F = 0.76), but not 
following any other dose (5.0 mg/kg,  strain effect, F = 2.07, P = 0.17, 
interaction effect, F = 0.54; 15 mg/kg,  strain effect, F = 0.6, interac- 
tion effect, F =  0.6; 30 mg/kg,  strain effect, F = 1.51, P =  0.23, 
interaction effect, F = 0.4). Group n values are the same as in Fig. 9. 
ment, as well as more pronounced behavioral symp- 
toms during naloxone precipitated withdrawal. Al- 
though Guitart  et al. [23] reported no difference be- 
tween LEW and F344 rats in the severity of opiate 
withdrawal, the symptoms of withdrawal exhibited by 
the two strains were qualitatively different. In sum- 
mary, the available evidence suggests that LEW rats 
are more sensitive than F344 rats to both the acute 
effects of a number  of addictive drugs, and to changes 
in drug effects associated with repeated drug treat- 
ment. 
4.2. Neural correlates of the LEW / F344 differences in 
behavioral responsiuity to addictive drugs 
The neurobiological basis for the differences be- 
tween LEW and F344 rats in the psychomotor-activat- 
Table 1 
Concentrations of methamphetamine, amphetamine or cocaine (mean + S.E.M.) measured in brain (ng /g  tissue) and plasma (ng/ml)  following 
an acute injection (i.p.) of methamphetamine or cocaine in LEW and F344 rats 
Strain mAMP (2.0 mg/kg)  Amphetamine Cocaine (10 mg/kg)  
40 min 120 min 40 min 120 min 40 min 80 min 
(n  = 5)  (n  = 5) (n  = 5)  (n = 5)  (n  = 5) (n  = 5) 
Brain tissue LEW 1759.6 + 151.6 * 601.6 _+ 21.0 * * 318.0 + 35.4 * 435.0 _+ 15.5 * * 522.8 +_ 119.6 * * * 80.0 _+ 21.0 
F344 948.4 + 110.8 199.2 + 15.4 197.1 -t- 14.2 106.8 -t- 7.8 285.0 _+ 74.7 61.6 + 10.3 
Plasma LEW 148.0 + 12.3 * 68.9 + 5.0 * * 37.5 + 3.7 * 53.2_+ 3.7 * * 251.5_ 89.7 * * * 44.6 + 14.0 
F344 95.2+ 8.3 23.7+ 2.8 22.9+ 1.5 15.5 + 2.6 88.2+ 26.2 27.8+ 5.1 
LEW differs from F344-* P < 0.01, * *P < 0.0001 (two-tailed t-test); * * * P < 0.01 if one rat excluded (see text). 
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ing and reinforcing effects of addictive drugs is not 
known, but we hypothesized that strain differences in 
the ability of these drugs to elevate the extracellular 
concentration of DA in the ventral striatum may play 
some role. Consistent with this, both mAMP and COC 
were found to elevate the extracellular concentration 
of DA in the ventral striatum to a greater extent in 
LEW rats compared to F344 rats. Furthermore,  the 
strain difference in mAMP-induced DA release was 
due largely to a difference in the duration of the 
response. Thus, strain differences in behavioral respon- 
sivity to mAMP and in mAMP-induced DA release 
were both largely characterized by differences in the 
duration of the response, with LEW rats showing a 
more sustained response than F344 rats. Similarly, 
delta-9-tetrahydrocannabinol produces a greater in- 
crease in extracellular DA in the nucleus accumbens of 
LEW rats, compared to Sprague-Dawley rats [8]. 
Although both mAMP and COC produced a greater 
increase in the extracellular concentration of DA in 
LEW rats, compared to F344 rats, there were some 
differences between the two drugs. The strain differ- 
ence in the COC-induced elevation in extracellular DA 
was smaller in comparison to that seen following 
mAMP, and also was not specifically associated with 
differences in the duration of the response. These may 
be due to differences in the mechanisms of action of 
mAMP vs. COC. 
In contrast to the findings reported here for COC, 
there have been two preliminary reports that acute 
administration of COC enhances the extracellular con- 
centration of DA to a greater extent in F344 rats 
compared to LEW rats [46,50]. The reason for this 
discrepancy is not clear. However, the results may be 
influenced by how the extracellular concentration of 
DA is expressed following drug administration. In the 
present study, the increase in extracellular DA is re- 
ported as a percent of baseline. If these same data are 
analyzed in terms of absolute values (data not pre- 
sented), there is no significant difference between LEW 
and F344 rats at any dose of COC tested. However, 
this still does not explain why in these other studies 
COC produced a greater increase in extracellular DA 
in F344 rats compared to LEW rats. Given that envi- 
ronmental factors seem to play a large role in produc- 
ing individual variability within the strains, perhaps 
differences in the environmental conditions between 
the present experiment and the previous experiments 
are important for these strain differences. Finally, it is 
possible that differences in probe placements and other 
procedural differences might acccount for the dis- 
crepant findings. 
It is important to note that the strain differences in 
stimulated DA activity were not associated with strain 
differences in basal levels of DA. However, basal levels 
of the DA metabolites, DOPAC and HVA, were higher 
in F344 rats. Basal metabolites in dialysate are thought 
to largely originate from the intraneuronal metabolism 
of DA, independent of DA release [29,53], and there- 
fore, may reflect the rate of DA synthesis. If this is 
true, then one might expect to see strain differences in 
tyrosine hydroxylase activity, the rate-limiting enzyme 
for DA synthesis. Indeed, LEW rats have higher levels 
of tyrosine hydroxylase in the VTA [2], and lower levels 
in the nucleus accumbens [2], striatum and midbrain 
[43], relative to F344 rats. The extent to which 
LEW /F 3 4 4  differences in tyrosine hydroxylase are re- 
lated to the differences in DA metabolites seen here is 
unknown. 
4.3. Pharmacokinetics 
Although many researchers have acknowledged the 
possibility that some of the differences between LEW 
and F344 rats in drug response may be due to pharma- 
cokinetics, there have been very few experiments de- 
signed to test this hypothesis. We are not aware of any 
previous studies on amphetamine pharmacokinetics in 
LEW vs. F344 rats, but in the present study plasma and 
brain levels of mAMP were two to three-fold higher in 
LEW rats compared to F344 rats following 2.0 mg /kg  
of mAMP (i.p.). Furthermore,  the magnitude of the 
strain difference in mAMP levels was larger at 2 h than 
at 40 min following mAMP administration, which is 
also when the behavioral and neurochemical differ- 
ences were greatest. We are aware of only one previ- 
ous study on COC pharmacokinetics in LEW and F344 
rats [22]. Guitart et al. [22] measured blood levels of 
COC at 15, 30 and 60 min after an injection of 15 
m g /k g  COC (i.p.) and found no differences between 
LEW and F344 rats. In contrast, we found that the 
levels of COC in plasma and in brain were higher in 
LEW rats compared to F344 rats 40 min following an 
injection of 10 m g /k g  COC (although there was a great 
deal of individual variation). Studies on morphine 
pharmacokinetics in LEW and F344 rats also are not 
entirely consistent [21,22]. Gosnell and Krahn [21] re- 
ported that the brain concentration of morphine fol- 
lowing a 3 m g / k g  s.c. injection of morphine was lower 
in LEW rats 30 min after the injection, but no different 
from F344 rats 3 h after the injection, whereas serum 
levels of morphine did not differ at 30 min, but were 
higher in LEW rats at 3 h. In contrast, Guitart et al. 
[22] reported that plasma levels of morphine did not 
differ between these two strains at 15, 30 and 60 min 
after a subcutaneous injection of 4 m g /k g  morphine 
sulfate. 
The reason(s) for the apparent differences between 
LEW and F344 rats in COC and mAMP pharmacoki- 
neties is unknown, and cannot be determined from this 
study. Strain differences in the rate of drug absorption, 
metabolism, distribution or elimination could be in- 
192 D.M. Camp et al, / Brain Research 668 (1994) 180-193 
volved. Indeed, differences between LEW and F344 
rats have been reported in hepatic catechol-O-methyl 
transferase (COMT) activity [51], and serum dopamine- 
/3-hydroxylase activity [45]. Whatever the mechanism, 
given the present interest in using LEW and F344 rats 
to study the neurobiology of addiction, the preliminary 
results reported here suggest more comprehensive 
studies on strain differences in drug pharmacokinetics 
are warranted. 
4.4. Conclusions 
In summary, it was found that both COC and mAMP 
produce greater psychomotor activation in LEW com- 
pared to F344 rats, and this was associated with differ- 
ences in the ability of these drugs to enhance the 
extracellular concentration of DA in the ventral stria- 
tum. These results extend the growing list of behavioral 
and biochemical differences in the effects of addictive 
drugs reported between these two strains. However, 
there were also strain differences in the plasma and 
brain concentrations of rnAMP and COC following 
systemic administration, suggesting strain differences 
in drug pharmacokinetics may contribute to these be- 
havioral and neurochemical effects. If confirmed this 
would have important implications for the notion that 
LEW rats may be especially vulnerable to addictive 
drugs. 
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